Karen J. Wilson - 14 Jan 2025 Form 3 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
Karen J. Wilson
Issuer symbol
SER
Transactions as of
14 Jan 2025
Net transactions value
$0
Form type
3
Filing time
15 Jan 2025, 16:17:50 UTC
Previous filing
02 Jan 2025
Next filing
18 Feb 2025

No securities are beneficially owned.